GlassScriptPhysician profile
Jaclyn Ulzheimer
NPI 1730644873
$1,094.51
in general payments reported to CMS, 2019-2025
17 companies · $651 in 2025
The $651 reported for 2025 was more than what 78% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $444 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901 · Long Term Medical Supply Or Device Loan: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.96 |
| Long Term Medical Supply Or Device Loan | $193.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $193.55 | 2024 | Video Colonoscope |
| Janssen Biotech, INC. | $177.52 | 2025 | Tremfya |
| Corcept Therapeutics | $140.69 | 2024 | Korlym |
| Qol Medical, LLC | $117.93 | 2024-2025 | Sucraid, Sucraid |
| Pfizer INC. | $84.50 | 2025 | |
| Madrigal Pharmaceuticals | $73.61 | 2025 | Rezdiffra |
| Regeneron Healthcare Solutions, INC. | $53.93 | 2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $53.29 | 2024-2025 | Entyvio, Eohilia |
| Genzyme Corporation | $44.57 | 2025 | |
| Lilly USA, LLC | $34.92 | 2024 | Omvoh |
| Kyowa Kirin, INC. | $19.98 | 2025 | |
| Ucb, INC. | $19.67 | 2025 | Bimzelx |
| Celltrion USA INC. | $18.83 | 2025 | Vegzelma |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.45 | 2025 | Xifaxan |
| Aimmune Therapeutics, INC. | $16.60 | 2025 | Zenpep |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $14.16 | 2025 | Wegovy |
| Abbvie INC. | $13.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Ulzheimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.